In addition, it is postulated that aberrant NF-κB signalling and EBV latent genes may jointly contribute to the initiation and progression of NPC tumourigenesis by promoting tumour proliferation, survival, and immunosuppression (Figure 4) [89]. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.